The Effects and Mechanisms of Dihydroartemisinin on Influenza A Virus H1N1 Induces TNF-α and IL-6 Expression in Bronchial Epithelial Cells

OU Li, QIN Ke, YANG Zi-xiao, BIE Ming-jiang

Abstract

To investigate the effects of dihydroartemis (DHA) on influenza A virus (IAV) A/PR/8/34 (H1N1) induces the pro-inflammatory factor and protein of extracellular signal regulated kinase (ERK) signaling pathway expression in bronchial epithelial cells.  Methods  The BEAS-2B cells were treated with different concentrations of DHA (i.e.,0, 12.5, 25, 50 and 100 μmol/L) for 24 h and the effect of DHA on the viability of BEAS-2B cells were measure by CCK8 method. The BEAS-2B cells were absorbed with IAV for 1 h, and then were treated with different concentrations of DHA (i.e., 12.5, 25 and 50 μmol/L) for 24 h, meanwhile, the normal control group and IAV group were established. The mRNA and protein expression levels of tumor necrosis factor-α (TNF-α) and interleukin (IL-6) were measured by real time quantitative PCR (RT-qPCR) and enzyme linked immunosorbent assay (ELISA), the expression levels of phospho-ERK (p-ERK) proteins were tested by Western blot (WB). Then, an ERK agonist (20 ng/mL) was used to treat BEAS-2B cells (the groups were divided into normal control group, DHA group, DHA+IAV group, ERK agonist group and DHA+IAV+ERK agonist group) for 24 h, and to observe the effect of DHA on inhibiting IAV induce the TNF-α, IL-6 and p-ERK expression in the BEAS-2B cells.  Results  The BEAS-2B cells viability was not significantly different from that of the normal control group after treatment with DHA (i.e., 12.5, 25, and 50 μmol/L). The expression levels of TNF-α, IL-6 mRNA and TNF-α, IL-6, p-ERK protein in IAV group were significantly up-regulated compared with that in the normal control group (P<0.05), meanwhile, compared with the IAV group, the expression levels of TNF-α, IL-6 mRNA and TNF-α, IL-6, p-ERK protein showed dose-dependent decrease in IAV+DHA group (P<0.05). However, ERK agonists attenuated the DHA inhibit IAV induced the proinflammatory factors TNF-α, IL-6 secretion and the p-ERK protein expression of ERK signaling pathway in BEAS-2B cells.  Conclusion  These data suggest that DHA can inhibit IAV induces the TNF-α and IL-6 expression in BEAS-2B cells through ERK signaling pathway.

 

Keywords: Dihydroartemis, Influenza A virus H1N1, ERK signaling pathway

 

Full Text:

PDF


References


HORIMOTO T， KAWAOKA Y. Influenza: lessons from past pandemics, warnings from current incidents. Nat Rev Microbiol，2005，3(8): 591–600.

LEE V J， HO Z J M， GOH E H， et al. Advances in measuring influenza burden of disease. Influenza Other Respi Viruses，2018，12(1): 3–9.

WANG C， LIU P， LUO J， et al. Geldanamycinreduces acute respiratory distress syndrome and promotes the survival of mice infected with the highly virulent H5N1influenza virus. Front Cell Infect Microbiol，2017，7: 267–277.

GU Y， HSU A C， PANG Z， et al. Role of the innate cytokine storm induced by the Influenza A virus. Viral Immunol，2019，32(6): 244–251.

DAI J P， WANG Q W， SU Y， et al. Oxymatrineinhibits influenza A virus replication and inflammation via TLR4, p38 MAPK and NF-κB pathways. Int J Mol Sc，2018，19(4): 965–981.

KAKURU A， JAGANNATHAN P， MUHINDO M K， et al. Dihydroartemisinin–piperaquine for the prevention of malaria in pregnancy. N Engl J Med，2016，374(10): 928–939.

SHI X， WANG L， REN L， et al. Dihydroartemisinin, an antimalarial drug, induces absent in melanoma 2 inflammasome activation and autophagy in human hepatocellular carcinoma HepG2215 cells. Phytother Res，2019，33(5): 1413–1425.

HAN Y， PHAM H T， XU H， et al. Antimalarial drugs and their metabolites are potent Zika virus inhibitors. J Med Virol，2019，91(7): 1182–1190.

YIN J， XIA W， ZHANG Y， et al. Role of dihydroartemisinin in regulating prostaglandin E2 synthesis cascade and inflammation in endothelial cells. Heart Vessels，2018，33(11): 1411–1422.

ZHANG Z， GU O M， ZHAO S， et al. ROS-JNK1/2-dependent activation of autophagy is required for the induction of anti-inflammatory effect of dihydroartemisinin in liver fibrosis. Free RadicBiol Med，2016，101: 272–283.

PHUNG T T， SUGAMATA R， UNO K， et al. Key role of regulated upon activation normal T-cell expressed and secreted, nonstructural protein1 and myeloperoxidase in cytokine storm induced by influenza virus PR-8 (A/H1N1) infection in A549 bronchial epithelial cells. Microbiol Immunol，2011，55(12): 874–884.

PAUL A T， GOHIL V M， BHUTANI K K. Modulating TNF-α signaling with natural products. Drug Disco Today，2006，11(15-16): 725–732.

ZHANG F， YAO S， ZHANG M， et al. Roles of circulating soluble interleukin (IL)-6 receptor and IL-6 receptor expression on CD4+ T cells in patients with chronic hepatitis B. Int J Infect Dis，2011，15(4): 267–271.

COURTIN N， FOTSO A F， FAUTRAD P， et al. Antiviral activity of formyl peptide receptor 2 antagonists against influenza viruses. Antiviral Res，2017，143(7): 252–261.

CANTAN B， LUYT C E， MARTIN L. Influenza infections and emergent viral infections in Intensive Care Unit. Semin Respir Crit Care Med， 2019，40(4): 488–497.

SHORT K R， KEDZIERSKA K， VAN DE SANDT C E. Back to the future: lessons learned from the 1918 Influenza Pandemic. Front Cell Infect Microbiol， 2018， 8: 343 [2020-02-17]. https://doi.org/10.3389/fcimb.2018.00343.


Refbacks

  • There are currently no refbacks.